In Brief: FDA Hematology Division
Executive Summary
FDA Hematology Division: Director Joseph Fratantoni, MD, leaves agency to join biologics consulting firm C.L. McIntosh & Associates as VP-biologics. Fratantoni has been director of the division since 1992 and has been involved in policymaking regarding Creutzfeldt-Jakob disease, blood substitutes and the review of erythropoietin...